PURPOSE To provide evidence-based recommendations to practicing clinicians on
management of patients with stage III non–small-cell lung cancer (NSCLC). METHODS An …

Background This is an updated version of the original review published in Issue 4, 2004.
The use of concurrent chemotherapy and radiotherapy in non‐small cell lung cancer …

Lung cancer remains the commonest cause of cancer death in both men and women in the
developed world, although mortality rates for men are dropping. Spiral computed …

Purpose We conducted a phase III study to compare the survival impact of concurrent versus
sequential treatment with radiotherapy (RT) and chemotherapy (CT) in unresectable stage III …

Purpose In lung cancer, randomized trials assessing hyperfractionated or accelerated
radiotherapy seem to yield conflicting results regarding the effects on overall (OS) or …

Background It is unknown whether combined chemoradiotherapy improves overall survival
in elderly patients with locally advanced non-small-cell lung cancer (NSCLC). The aim of …

Background Despite several randomised trials comparing radiotherapy alone with
concomitant radio-chemotherapy in patients with locally advanced non-small cell lung …

Purpose: Most radical radiotherapy (RT) candidates with non–small-cell lung cancer
(NSCLC) have Stage III disease and ultimately die with distant metastases. We tested the …

A randomised phase III study was performed comparing sequential (S) and concurrent (C)
chemo-radiotherapy (CRT) in non-small cell lung cancer (NSCLC) patients. METHODS: One …

BACKGROUND Successful treatment of nonsmall cell lung carcinoma (NSCLC) with radical
radiotherapy (RT) requires accurate delineation of tumor extent. Conventional computed …